CD8A and COVID-19: Decreased level of GZMK mRNA, as well as a decreased proportion of effector memory CD8+ T cells that produce GZMK, was observed in the peripheral blood of COVID-19 patients compared to healthy subjects (Ramljak et al., 2021).